Research

An efficient path to therapeutic development

The Center for Experimental Therapeutics creates a hub at OHSU for global collaboration with pharma, biotech, foundations and investors, and more.

The Center for Experimental Therapeutics creates a hub for institutes and centers at OHSU to foster global collaboration with pharma, biotech, foundations and investors, and leads to licensing and commercialization.
The Center for Experimental Therapeutics works with OHSU’s Knight Cancer Institute, Vollum Institute, Knight Cardiovascular Institute, Vaccine and Gene Therapy Institute, Oregon National Primate Research Center, Brenden-Colson Center, Center for Regenerative Medicine, Brain Institute, and more.

Interested in working together?

Become a CET member

CET membership is open to anyone at OHSU with an interest in advancing drug discovery and development. Members receive periodic email communication about events, programming, news and funding opportunities.

We focus on drug discovery and development to treat a range of diseases and improve health outcomes

Focus areas:

  • Cancer- solid tumors and hematological malignancies
  • Drugs to treat cardiovascular diseases
  • Anti-infective agents
  • Drugs to treat neurologic disorders
  • Radiation sensitizers and protectors
  • Stem cells

The center supports clinicians and scientists in a variety of ways:

  • Small molecule chemical probes
  • Animal models
  • Assay development
  • Bioinformatics and big data
  • Diagnostics
  • Disease biology
  • Early detection
  • Imaging
  • Medicinal chemistry
  • Molecular profiling
  • Regulatory
  • Target ID and validation
  • Clinical trial design, including first-in-human trials

Robust technology and resources for cancer researchers

The center has access to state-of-the-art technology, resources and expertise to help our investigators reach their scientific goals, including:

  • Advanced Multiscale Microscopy
  • BioLibrary and Pathology
  • Biostatistics
  • Flow Cytometry
  • Integrated Genomics
  • Proteomics